VU-0152099: Difference between revisions
CSV import |
CSV import |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{ | {{DISPLAYTITLE:VU-0152099}} | ||
}} | |||
'''VU-0152099''' is a chemical compound that acts as a selective | == Overview == | ||
'''VU-0152099''' is a chemical compound that acts as a selective [[M1 receptor]] positive allosteric modulator. It is primarily used in [[scientific research]] to study the [[M1 muscarinic receptor]] and its role in [[cognitive function]] and [[neurological disorders]]. | |||
== | == Chemical Structure == | ||
VU-0152099 | [[File:VU-0152099.svg|thumb|right|Chemical structure of VU-0152099]] | ||
VU-0152099 is characterized by its unique chemical structure, which allows it to selectively bind to the M1 muscarinic receptor. This selectivity is crucial for its role in modulating receptor activity without affecting other [[muscarinic receptors]]. | |||
== Mechanism of Action == | == Mechanism of Action == | ||
VU-0152099 binds to | VU-0152099 functions as a positive allosteric modulator of the M1 receptor. This means that it binds to a site on the receptor distinct from the [[orthosteric site]] where the endogenous ligand, [[acetylcholine]], binds. By binding to this allosteric site, VU-0152099 enhances the receptor's response to acetylcholine, thereby potentiating its effects. | ||
== Research Applications == | == Research Applications == | ||
The compound is extensively used in [[preclinical studies]] to explore the therapeutic potential of M1 receptor modulation. It has been investigated for its effects on [[memory]], [[learning]], and [[synaptic plasticity]]. Researchers are particularly interested in its potential applications in treating [[Alzheimer's disease]] and other [[cognitive disorders]]. | |||
== Pharmacological Effects == | |||
Studies have shown that VU-0152099 can improve cognitive performance in animal models. It has been observed to enhance [[long-term potentiation]] (LTP) in the [[hippocampus]], a brain region critical for memory formation. These effects are attributed to its ability to modulate M1 receptor activity. | |||
== Safety and Toxicology == | == Safety and Toxicology == | ||
As | As with many research chemicals, the safety profile of VU-0152099 is not fully established. It is primarily used in controlled laboratory settings, and its effects in humans are not well-documented. Researchers must handle it with care, following appropriate safety protocols. | ||
== Future Directions == | |||
The ongoing research aims to better understand the role of M1 receptor modulation in cognitive processes and its potential therapeutic applications. VU-0152099 serves as a valuable tool in this research, helping to elucidate the complex mechanisms underlying [[neurotransmission]] and [[neurodegeneration]]. | |||
== | == Related Pages == | ||
* [[ | * [[M1 receptor]] | ||
* [[Muscarinic acetylcholine receptor]] | |||
* [[Allosteric modulator]] | * [[Allosteric modulator]] | ||
* [[ | * [[Cognitive enhancement]] | ||
[[Category:Pharmacology]] | [[Category:Pharmacology]] | ||
[[Category:Research chemicals]] | [[Category:Research chemicals]] | ||
Latest revision as of 03:47, 13 February 2025
Overview[edit]
VU-0152099 is a chemical compound that acts as a selective M1 receptor positive allosteric modulator. It is primarily used in scientific research to study the M1 muscarinic receptor and its role in cognitive function and neurological disorders.
Chemical Structure[edit]
VU-0152099 is characterized by its unique chemical structure, which allows it to selectively bind to the M1 muscarinic receptor. This selectivity is crucial for its role in modulating receptor activity without affecting other muscarinic receptors.
Mechanism of Action[edit]
VU-0152099 functions as a positive allosteric modulator of the M1 receptor. This means that it binds to a site on the receptor distinct from the orthosteric site where the endogenous ligand, acetylcholine, binds. By binding to this allosteric site, VU-0152099 enhances the receptor's response to acetylcholine, thereby potentiating its effects.
Research Applications[edit]
The compound is extensively used in preclinical studies to explore the therapeutic potential of M1 receptor modulation. It has been investigated for its effects on memory, learning, and synaptic plasticity. Researchers are particularly interested in its potential applications in treating Alzheimer's disease and other cognitive disorders.
Pharmacological Effects[edit]
Studies have shown that VU-0152099 can improve cognitive performance in animal models. It has been observed to enhance long-term potentiation (LTP) in the hippocampus, a brain region critical for memory formation. These effects are attributed to its ability to modulate M1 receptor activity.
Safety and Toxicology[edit]
As with many research chemicals, the safety profile of VU-0152099 is not fully established. It is primarily used in controlled laboratory settings, and its effects in humans are not well-documented. Researchers must handle it with care, following appropriate safety protocols.
Future Directions[edit]
The ongoing research aims to better understand the role of M1 receptor modulation in cognitive processes and its potential therapeutic applications. VU-0152099 serves as a valuable tool in this research, helping to elucidate the complex mechanisms underlying neurotransmission and neurodegeneration.
